The effects of umespirone as a potential anxiolytic and antipsychotic agent
- 30 September 1991
- journal article
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 40 (1) , 89-96
- https://doi.org/10.1016/0091-3057(91)90326-w
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Exploration of mice in a black and white test box: Validation as a model of anxietyPublished by Elsevier ,2002
- Binding of umespirone to the σ receptor: Evidence for multiple affinity statesNeuropharmacology, 1990
- 5-HT1A receptor-related anxiolyticsTrends in Pharmacological Sciences, 1987
- Animal models of anxiety: the effect of compounds that modify 5-HT neurotransmissionTrends in Pharmacological Sciences, 1987
- Withdrawal syndrome following subchronic treatment with anxiolytic agentsPharmacology Biochemistry and Behavior, 1987
- Is it possible to model psychotic states in animals?Journal of Psychopharmacology, 1987
- Are there selective ligands for 5-HT1A and 5-HT1B receptor binding sites in brain?Trends in Pharmacological Sciences, 1986
- Buspirone decreases the activity of 5-hydroxytryptamine-containing dorsal raphe neurons in-vitroJournal of Pharmacy and Pharmacology, 1986
- Long-term consequences of antagonism by neuroleptics of behavioural events occurring during mesolimbic dopamine infusionNeuropharmacology, 1984
- Clozapine and the Dopamine Hypothesis of Schizophrenia, a Critical AppraisalPharmacopsychiatry, 1975